Quantifying the utilization of medical devices necessary to detect postmarket safety differences: A case study of implantable cardioverter defibrillators

Pharmacoepidemiology and Drug Safety, EarlyView.

Source: Pharmacoepidemiology and Drug Safety - June 13, 2018 Category: Drugs & Pharmacology Authors: JonathanBates , Craig S.Parzynski , Sanket S.Dhruva , AndreasCoppi , RichardKuntz , Shu ‐XiaLi , DanicaMarinac‐Dabic , Frederick A.Masoudi , Richard E.Shaw , FrederickWarner , Harlan M.Krumholz , Joseph S.Ross Source Type: research